SCOPUS 정보 검색 플랫폼

Breast Cancer Research

Volumn 4, Issue 4, 2002, Pages 133-136

Estrogen as therapy for breast cancer

(1) Ingle, James N a

a MAYO CLINIC (United States)

Author keywords

Breast cancer; Dose response; Endocrine therapy; Estrogen

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; ANTINEOPLASTIC AGENT; ESTRADIOL; ESTROGEN; EXEMESTANE; LETROZOLE; MEGESTROL ACETATE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; TAMOXIFEN; VOROZOLE;

ARTICLE; BREAST CANCER; CANCER CELL; CLINICAL ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; SIDE EFFECT;

ANDROSTADIENES; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE II; DIETHYLSTILBESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ESTROGENS; FEMALE; HUMANS; MEGESTROL ACETATE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; POSTMENOPAUSE; SALVAGE THERAPY; TAMOXIFEN; TREATMENT OUTCOME; TRIAZOLES;

EID: 0036041129 PISSN: 14655411 EISSN: None Source Type: Journal
DOI: 10.1186/bcr436 Document Type: Article

Times cited : (57)

References (19)

1
- 0015069359
- A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474
- (1971) Br. J. Cancer , vol.25 , pp. 270-275
- Cole, M.P.¹ Jones, C.T.A.² Todd, I.D.H.³

2
- 0019382847
- Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer
- (1981) N. Engl. J. Med , vol.304 , pp. 16-21
- Ingle, J.N.¹ Ahmann, D.L.² Green, S.J.³ Edmonson, J.H.⁴ Bisel, H.F.⁵ Kvols, L.K.⁶ Nichols, W.C.⁷ Creagan, E.T.⁸ Hahn, R.G.⁹ Rubin, J.¹⁰ Frytak, S.¹¹

3
- 0019236420
- The tamoxifen trial: A double-blind comparison with Stilboestrol in postmenopausal women with advanced breast cancer
- Edited by Mouridsen HT, Palshof T. Oxford: Pergamon Press
- (1980) Breast Cancer: Experimental and Clinical Aspects , pp. 83-88
- Stewart, H.J.¹ Forrest, A.P.M.² Gunn, J.M.³ Hamilton, T.⁴ Langlands, A.O.⁵ McFadyen, I.J.⁶ Roberts, M.M.⁷

4
- 0033058968
- Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis
- (1999) Breast Cancer Res. Treat , vol.54 , pp. 117-122
- Peethambaram, P.P.¹ Ingle, J.N.² Suman, V.J.³ Hartmann, L.C.⁴ Loprinzi, C.L.⁵

5
- 0034891355
- High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy
- (2001) Breast Cancer Res. Treat , vol.67 , pp. 111-116
- Lønning, P.E.¹ Taylor, P.D.² Anker, G.³ Iddon, J.⁴ Wie, L.⁵ Jørgensen, L.-M.⁶ Mella, O.⁷ Howell, A.⁸

6
- 0025328579
- Diethylstilbestrol revisted in advanced breast cancer management
- (1990) Med. Pediatr. Oncol , vol.18 , pp. 317-320
- Boyer, M.J.¹ Tattersall, M.H.N.²

7
- 0032729804
- Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer
- (1999) J. Clin. Oncol , vol.17 , pp. 3418-3425
- Jones, S.¹ Vogel, C.² Arkhipov, A.³ Fehrenbacher, L.⁴ Eisenberg, P.⁵ Cooper, B.⁶ Honig, S.⁷ Polli, A.⁸ Whaley, F.⁹ di Salle, E.¹⁰ Tiffany, J.¹¹ Consonni, A.¹² Miller, L.¹³

8
- 0030927955
- A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma
- (1997) Cancer , vol.80 , pp. 218-224
- Ingle, J.N.¹ Johnson, P.A.² Suman, V.J.³ Gerstner, J.B.⁴ Mailliard, J.A.⁵ Camoriano, J.K.⁶ Gesme, D.H.⁷ Loprinzi, C.L.⁸ Hatfield, A.K.⁹ Hartmann, L.C.¹⁰

9
- 0345596372
- Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminolugtethimide: A phase II multicentre, multinational study
- (1997) Eur. J. Cancer , vol.33 , pp. 1767-1773
- Thürlimann, B.¹ Paridaens, R.² Serin, D.³ Bonneterre, J.⁴ Roche, H.⁵ Murray, R.⁶ di Salle, E.⁷ Lanzalone, S.⁸ Zurlo, M.G.⁹ Piscitelli, G.¹⁰

10
- 17144472154
- Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors
- (2000) J. Clin. Oncol , vol.18 , pp. 2234-2244
- Lønning, P.E.¹ Bajetta, E.² Murray, R.³ Tubiana-Hulin, M.⁴ Eisenberg, P.D.⁵ Mickiewicz, E.⁶ Celio, L.⁷ Pitt, P.⁸ Mita, M.⁹ Aaronson, N.K.¹⁰ Fowst, C.¹¹ Arkhipov, A.¹² di Salle, E.¹³ Polli, A.¹⁴ Massimini, G.¹⁵

11
- 8944237006
- Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: Results of overview analysis of two phase III trials
- Arimidex Study Group
- (1996) J. Clin. Oncol , vol.14 , pp. 2000-2011
- Buzdar, A.¹ Jonat, W.² Howell, A.³ Jones, S.E.⁴ Blomqvist, C.⁵ Vogel, C.L.⁶ Eiermann, W.⁷ Wolter, J.M.⁸ Azab, M.⁹ Webster, A.¹⁰ Plourde, P.V.¹¹

12
- 0034128928
- Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial
- (2000) J. Clin. Oncol , vol.18 , pp. 1399-1411
- Kaufmann, M.¹ Bajetta, E.² Dirix, L.Y.³ Fein, L.E.⁴ Jones, S.E.⁵ Zilembo, N.⁶ Dugardyn, J.-L.⁷ Nasurdi, C.⁸ Mennel, R.G.⁹ Cervek, J.¹⁰ Fowst, C.¹¹ Polli, A.¹² di Salle, E.¹³ Arkhipov, A.¹⁴ Piscitelli, G.¹⁵ Miller, L.L.¹⁶ Massimini, G.¹⁷

13
- 0031943424
- Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate
- (1998) J. Clin. Oncol , vol.16 , pp. 453-461
- Dombernowsky, P.¹ Smith, I.² Falkson, G.³ Leonard, R.⁴ Panasci, L.⁵ Bellmunt, J.⁶ Bezwoda, W.⁷ Gardin, G.⁸ Gudgeon, A.⁹ Morgan, M.¹⁰ Fornasiero, A.¹¹ Hoffman, W.¹² Michel, J.¹³ Hatschek, T.¹⁴ Tjabbes, T.¹⁵ Chaudri, H.A.¹⁶ Hornberger, U.¹⁷ Trunet, P.F.¹⁸

14
- 0028853923
- Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
- (1995) J. Clin. Endocrinol. Metab , vol.80 , pp. 2918-2925
- Masamura, S.¹ Santner, S.J.² Heitjan, D.F.³ Santen, R.J.⁴

15
- 0036467847
- Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study
- (2002) J. Clin. Oncol , vol.20 , pp. 751-757
- Geisler, J.¹ Haynes, B.² Anker, G.³ Dowsett, M.⁴ Lønning, P.E.⁵

16
- 0035930095
- Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17β-estradiol
- (2001) J. Natl. Cancer Inst , vol.93 , pp. 1714-1723
- Song, R.X.-D.¹ Mor, G.² Naftolin, F.³ McPherson, R.A.⁴ Song, J.⁵ Zhang, Z.⁶ Yue, W.⁷ Wang, J.⁸ Santen, R.J.⁹

17
- 0017740963
- Diethylstilbestrol: Recommended dosages for different categories of breast cancer patients
- (1977) JAMA , vol.237 , pp. 2079-2085
- Carter, A.C.¹ Sedransk, N.² Kelley, R.M.³ Ansfield, F.J.⁴ Ravdin, R.G.⁵ Talley, R.W.⁶ Potter, N.R.⁷

18
- 0028839029
- Estrogen replacement therapy withdrawal and regression of metastatic breast cancer
- (1995) Cancer , vol.75 , pp. 43-46
- Dhodapkar, M.V.¹ Ingle, J.N.² Ahmann, D.L.³

19
- 0035667428
- Future use of selective estrogen receptor modulators and aromatase inhibitors
- (2001) Clin. Cancer Res , vol.7 , Issue.SUPPL.
- Howell, A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.